Experts believe that pharma will continue as normal due to the scientific justification of running diverse clinical trials.

Despite a dip in base business revenue, Gland Pharma Ltd (NSE:GLAND) reports robust margin improvements and strategic growth initiatives.

Novartis AG (NYSE:NVS), a global healthcare powerhouse with a market capitalization of $208.27 billion, has recently transformed into a pure-play pharmaceutical company, sharpening its focus on its ...

Carl Rizzuto, Versant Ventures managing director, joins 'Fast Money' to talk the impact of tariffs on healthcare.

Europeans are being warned of the dangers of counterfeit medications after police squads across the continent reported ...

Ligand Pharmaceuticals stock is on the rise with optimistic analyst ratings and a plan for 20% annual revenue growth. Learn ...

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, ...

Ascendis Pharma boasts several commercial stage products. Read why ASND stock is an interesting speculative investment ...